| ORIGINAL ARTICLE |
|
| Year : 2005 | Volume
: 21
| Issue : 1 | Page : 59-62 |
|
|
Chyluria - SGPGI experience
A Suri, A Kumar
Department of Urology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
Correspondence Address:
A Kumar
Department of Urology, Lucknow,Uttar Pradesh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0970-1591.19554
|
|
|
Purpose:0 We analyzed various modes of presentation of chyluria in our patients. Various treatment options available and associated complications were also studied. Materials and methods:0 Retrospective review of records of patients of chyluria treated at our institute between January1987 to June 2005 was done. Chyluria was diagnosed by urine examination. Treatment was tailored according to severity of chyluria, which included dietary modification, antifilarial drugs and sclerotherapy. Those not responding to two sessions of sclerotherapy were taken up for chylolymphatic disconnection. Results:0 A total of 600 patients were treated between January 1987 and June 2005. Before 1999 we routinely used 1% silver nitrate. Between January 1999 and June 2003, povidone iodine (0.2%) and dextrose (50%) were also used besides silver nitrate (1%). Instillation of dextrose was used in 21 patients only and its use was discontinued because of high immediate failure (57%) and recurrence rate (38%). Instillation of povidone iodine was as effective as silver nitrate. 91% of the patients in the silver nitrate and 98% in the povidone group showed immediate clearance. The chyluria recurred in 21 and 22% in two groups, respectively. The cumulative success rate after two courses of sclerotherapy was 82% in the silver nitrate and 83% in the povidone group. Side effects were much less with povidone iodine. Those who did not responded to two courses of sclerotherapy did well after chylolymphatic disconnection. Conclusion:0 Presenting symptoms of chyluria vary according to severity of the disease. Most patients respond to dietary modifications, antifilarial drugs and sclerotherapy. Those not responding to sclerotherapy do well after chylolymphatic disconnection. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
